Francesca Spanda, Medical Oncologist Assistant of Gastrointestinal Medical Oncology and Neuroendocrine Tumors Division, European Institute of Oncology, shared a post on X:
“The best way to start ESMO2024 for neuroendocrine community! Amazing session, brilliant speakers, vibrant discussions. Lovely friends and colleagues and more
- CMV-118 in progressive NET
- CABONEN in low G3 NEN
- NETTER-2 and new insights
- Carcinoid heart disease and NET
Source: Francesca Spanda/X